PHARMACYTE BIOTECH INC (PMCB) Stock Cash Flow
USA - NASDAQ:PMCB - US71715X2036 - Common Stock
1.025 USD
+0.01 (+1.49%)
| TTM (2025-7-31) | 2025 (2025-4-30) | 2024 (2024-4-30) | 2023 (2023-4-30) | 2022 (2022-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -1.13M | 30.66M | 333.80K | -4.32M | -4.24M | |||
| Change In Working Capital | -193.20K | 1.36M | 298.90K | -300.00K | 10.00K | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Taxes Paid | N/A | 0.00 | 1.60K | 0.00 | 0.00 | |||
| Other non cash items | -3.28M | -34.99M | -2.78M | 820.00K | 110.00K | |||
| OPERATING CASH FLOW | -4.60M | -2.98M | -2.15M | -3.79M | -4.12M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | 0.00 | -7.00M | -5.00M | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | 0.00 | -7.00M | -5.00M | 0.00 | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | -50.00K | |||
| Stock Issued/Repurchased | -14.86M | -25.03M | -10.71M | -13.56M | 87.36M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -14.86M | -25.03M | -10.71M | -13.56M | 87.31M | |||
| Exchange Rate Effect | -500.00 | -400.00 | -500.00 | -10.00K | 0.00 | |||
| CHANGE IN CASH | -19.46M | -35.01M | -17.86M | -17.36M | 83.19M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.60M | -2.98M | -2.15M | -3.79M | -4.12M | |||
| FREE CASH FLOW | -4.60M | -2.98M | -2.15M | -3.79M | -4.12M | |||
All data in USD